NuVasive(R) to Sponsor the 5th Annual San Diego Festival of Science and Engineering Expo Day

NuVasive(R) to Sponsor the 5th Annual San Diego Festival of Science and 
Engineering Expo Day 
SAN DIEGO, CA -- (Marketwire) -- 03/19/13 --  NuVasive, Inc. (NASDAQ:
NUVA), a medical device company focused on developing minimally
disruptive surgical products and procedures for the spine, is excited
to sponsor the 5th Annual San Diego Festival of Science and
Engineering Expo Day on Saturday, March 23, 2013 from 10:00 a.m. to
5:00 p.m. at Petco Park, booth #HP16-17. 
The San Diego Festival of Science and Engineering features
interactive demonstrations and hands-on activities to inspire today's
students to become tomorrow's science, technology, engineering, and
math (STEM) innovators. 
"Expo day is a great opportunity to showcase the importance of
innovation," said Alex Lukianov, NuVasive Chairman and Chief
Executive Officer. "Over the last century, the United States has been
the world leader in developing new technologies to advance the
quality of health care. It is critical that we continue to take the
time to educate our children and young adults on how innovation not
only dramatically advances the quality of health care, but how it
changes patients' lives." 
As a global leader in the spine industry, NuVasive is transforming
health care by pioneering innovative surgical solutions to change
spine surgery. Through technological advancements, NuVasive has
successfully turned invasive spine surgery into the equivalent of
outpatient surgery, with some patients often walking the same day of
surgery. The ultimate focus is improving the lives of patients who
suffer from debilitating back, neck or leg pain and is what drives
the company to create products and procedures that truly make a
difference.  
Through investments in innovation, over 100,000 patients from all
walks of life, including celebrities like Bill Walton, have
benefitted from this new technology and superior clinical outcomes.  
Basketball Hall-of-Famer and The Better Way Back(R) patient
ambassador, Bill Walton underwent the NuVasive minimally disruptive
technique called eXtreme Lateral Interbody Fusion (XLIF(R)) at age
fifty-six after all other non-surgical options had been explored.
After the procedure, he was amazed by the immediate relief from the
unrelenting and excruciating nerve pain that had r
un through his back
and down his legs for most of his adult life. Bill Walton went from
contemplating suicide because of the debilitating pain to now living
each day to the fullest and "getting his life back."  
Bill Walton will be at the NuVasive booth from 10:30 a.m. to 12:00
p.m., signing autographs and discussing how the innovative XLIF
procedure changed his life. 
For more information on Expo Day please visit:
http://www.sdsciencefestival.com/  
About NuVasive 
NuVasive is a medical device company focused on developing minimally
disruptive surgical products and procedurally integrated solutions
for the spine. The Company is the 4th largest player in the $8.2
billion global spine market. NuVasive's principal product offering is
based on its Maximum Access Surgery, or MAS(R) platform. The MAS
platform combines several categories of solutions that collectively
minimize soft tissue disruption during spine surgery with maximum
visualization and safe, easy reproducibility for the surgeon: a
proprietary software-driven nerve avoidance system and
intra-operative monitoring support; MaXcess(R), a unique split-blade
retractor system; a wide variety of specialized implants; and several
biologic products to aid in the spinal fusion process. MAS
significantly reduces surgery time and returns patients to activities
of daily living much faster than conventional approaches. Having
redefined spine surgery with the MAS platform's lateral approach,
known as eXtreme Lateral Interbody Fusion, or XLIF(R), NuVasive has
built an entire spine franchise. With over 80 products today spanning
lumbar, thoracic and cervical applications, the Company will continue
to expand and evolve its offering predicated on its R&D focus and
dedication to outstanding service levels supported by a culture of
Absolute Responsiveness(R).  
NuVasive cautions you that statements included in this press release
that are not a description of historical facts are forward-looking
statements that involve risks, uncertainties, assumptions and other
factors which, if they do not materialize or prove correct, could
cause NuVasive's results to differ materially from historical results
or those expressed or implied by such forward-looking statements. The
potential risks and uncertainties are described in NuVasive's press
releases and periodic filings with the Securities and Exchange
Commission. NuVasive's public filings with the Securities and
Exchange Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect events
or circumstances arising after the date on which it was made. 
Investor Contact:
Stephan Ogilvie 
VP, Corporate Development & Investor Relations
NuVasive, Inc.
201-322-6515
investorrelations@nuvasive.com  
Media: 
Nicole Collins
NuVasive, Inc.
858-909-1907
media@nuvasive.com